Merck and Co Inc , which has to a great extent kept to the sidelines of the race for COVID-19 medications, said it was purchasing Austrian antibody creator Themis Bioscience and would work together with inquire about not-for-profit IAVI to create two separate immunizations. It likewise declared an organization with secretly held Ridgeback Biotherapeutics to…